
### [MONDO:0002562](http://purl.obolibrary.org/obo/MONDO_0002562)
**Label:** demyelinating disease

**Subclasses:** [MONDO:0013893](http://purl.obolibrary.org/obo/MONDO_0013893) (multiple sclerosis, susceptibility to, 5), [MONDO:0019100](http://purl.obolibrary.org/obo/MONDO_0019100) (neuromyelitis optica), [MONDO:0000713](http://purl.obolibrary.org/obo/MONDO_0000713) (Balo concentric sclerosis), [MONDO:0006915](http://purl.obolibrary.org/obo/MONDO_0006915) (polyradiculoneuropathy), [MONDO:0016171](http://purl.obolibrary.org/obo/MONDO_0016171) (polyradiculoneuropathy associated with IgG/IgA/IgM monoclonal gammopathy without known antibodies), [MONDO:0016170](http://purl.obolibrary.org/obo/MONDO_0016170) (chronic polyradiculoneuropathy), [MONDO:0006702](http://purl.obolibrary.org/obo/MONDO_0006702) (chronic inflammatory demyelinating polyradiculoneuropathy), [MONDO:0003334](http://purl.obolibrary.org/obo/MONDO_0003334) (demyelinating polyneuropathy), [MONDO:0005314](http://purl.obolibrary.org/obo/MONDO_0005314) (relapsing-remitting multiple sclerosis), [MONDO:0000450](http://purl.obolibrary.org/obo/MONDO_0000450) (secondary progressive multiple sclerosis), [MONDO:0000451](http://purl.obolibrary.org/obo/MONDO_0000451) (primary progressive multiple sclerosis), [MONDO:0005301](http://purl.obolibrary.org/obo/MONDO_0005301) (multiple sclerosis), [MONDO:0000452](http://purl.obolibrary.org/obo/MONDO_0000452) (progressive relapsing multiple sclerosis), [MONDO:0012958](http://purl.obolibrary.org/obo/MONDO_0012958) (MS4), [MONDO:0002960](http://purl.obolibrary.org/obo/MONDO_0002960) (polyradiculopathy), [MONDO:0021571](http://purl.obolibrary.org/obo/MONDO_0021571) (multiple sclerosis, susceptibility to 1), [MONDO:0005284](http://purl.obolibrary.org/obo/MONDO_0005284) (chronic progressive multiple sclerosis), [MONDO:0007462](http://purl.obolibrary.org/obo/MONDO_0007462) (multiple sclerosis, susceptibility to), [MONDO:0006692](http://purl.obolibrary.org/obo/MONDO_0006692) (central pontine myelinolysis), [MONDO:0007691](http://purl.obolibrary.org/obo/MONDO_0007691) (Guillain-Barre syndrome), [MONDO:0012957](http://purl.obolibrary.org/obo/MONDO_0012957) (MS3), [MONDO:0018826](http://purl.obolibrary.org/obo/MONDO_0018826) (Lewis-Sumner syndrome), [MONDO:0012956](http://purl.obolibrary.org/obo/MONDO_0012956) (MS2), 

**Mapped go classes:** [GO:0042531](http://purl.obolibrary.org/obo/GO_0042531) (positive regulation of tyrosine phosphorylation of STAT protein), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0002631](http://purl.obolibrary.org/obo/GO_0002631) (regulation of granuloma formation), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0008219](http://purl.obolibrary.org/obo/GO_0008219) (cell death), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0048002](http://purl.obolibrary.org/obo/GO_0048002) (antigen processing and presentation of peptide antigen), [GO:1990405](http://purl.obolibrary.org/obo/GO_1990405) (protein antigen binding), [GO:0019882](http://purl.obolibrary.org/obo/GO_0019882) (antigen processing and presentation), [GO:0032288](http://purl.obolibrary.org/obo/GO_0032288) (myelin assembly), [GO:0019886](http://purl.obolibrary.org/obo/GO_0019886) (antigen processing and presentation of exogenous peptide antigen via MHC class II), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0050728](http://purl.obolibrary.org/obo/GO_0050728) (negative regulation of inflammatory response), [GO:0034341](http://purl.obolibrary.org/obo/GO_0034341) (response to interferon-gamma), [GO:0050729](http://purl.obolibrary.org/obo/GO_0050729) (positive regulation of inflammatory response), [GO:0008630](http://purl.obolibrary.org/obo/GO_0008630) (intrinsic apoptotic signaling pathway in response to DNA damage), [GO:0006693](http://purl.obolibrary.org/obo/GO_0006693) (prostaglandin metabolic process), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0032715](http://purl.obolibrary.org/obo/GO_0032715) (negative regulation of interleukin-6 production), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0031902](http://purl.obolibrary.org/obo/GO_0031902) (late endosome membrane), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0043120](http://purl.obolibrary.org/obo/GO_0043120) (tumor necrosis factor binding), [GO:1903140](http://purl.obolibrary.org/obo/GO_1903140) (regulation of establishment of endothelial barrier), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0097190](http://purl.obolibrary.org/obo/GO_0097190) (apoptotic signaling pathway), [GO:0042552](http://purl.obolibrary.org/obo/GO_0042552) (myelination), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0046635](http://purl.obolibrary.org/obo/GO_0046635) (positive regulation of alpha-beta T cell activation), [GO:0002344](http://purl.obolibrary.org/obo/GO_0002344) (B cell affinity maturation), [GO:0002455](http://purl.obolibrary.org/obo/GO_0002455) (humoral immune response mediated by circulating immunoglobulin), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0002579](http://purl.obolibrary.org/obo/GO_0002579) (positive regulation of antigen processing and presentation), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:0042605](http://purl.obolibrary.org/obo/GO_0042605) (peptide antigen binding), [GO:0006952](http://purl.obolibrary.org/obo/GO_0006952) (defense response), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0002504](http://purl.obolibrary.org/obo/GO_0002504) (antigen processing and presentation of peptide or polysaccharide antigen via MHC class II), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0030593](http://purl.obolibrary.org/obo/GO_0030593) (neutrophil chemotaxis), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:0042613](http://purl.obolibrary.org/obo/GO_0042613) (MHC class II protein complex), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0005031](http://purl.obolibrary.org/obo/GO_0005031) (tumor necrosis factor-activated receptor activity), [GO:0051291](http://purl.obolibrary.org/obo/GO_0051291) (protein heterooligomerization), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0010977](http://purl.obolibrary.org/obo/GO_0010977) (negative regulation of neuron projection development), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0032760](http://purl.obolibrary.org/obo/GO_0032760) (positive regulation of tumor necrosis factor production), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0015643](http://purl.obolibrary.org/obo/GO_0015643) (toxic substance binding), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0033209](http://purl.obolibrary.org/obo/GO_0033209) (tumor necrosis factor-mediated signaling pathway), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0072659](http://purl.obolibrary.org/obo/GO_0072659) (protein localization to plasma membrane), [GO:0033160](http://purl.obolibrary.org/obo/GO_0033160) (positive regulation of protein import into nucleus, translocation), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0002381](http://purl.obolibrary.org/obo/GO_0002381) (immunoglobulin production involved in immunoglobulin mediated immune response), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0005771](http://purl.obolibrary.org/obo/GO_0005771) (multivesicular body), [GO:0009615](http://purl.obolibrary.org/obo/GO_0009615) (response to virus), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0005769](http://purl.obolibrary.org/obo/GO_0005769) (early endosome), [GO:0005923](http://purl.obolibrary.org/obo/GO_0005923) (bicellular tight junction), [GO:0043218](http://purl.obolibrary.org/obo/GO_0043218) (compact myelin), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0032060](http://purl.obolibrary.org/obo/GO_0032060) (bleb assembly), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0042130](http://purl.obolibrary.org/obo/GO_0042130) (negative regulation of T cell proliferation), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0002827](http://purl.obolibrary.org/obo/GO_0002827) (positive regulation of T-helper 1 type immune response), [GO:0071346](http://purl.obolibrary.org/obo/GO_0071346) (cellular response to interferon-gamma), 

**Class expressions from DL-Learner:**

- Thing 53.13%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 52.08%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 52.08%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 37.44%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2000976](http://purl.obolibrary.org/obo/GO_2000976) (obsolete regulation of transcription from RNA polymerase II promoter involved in detection of glucose)) 37.44%


